挪威长期未参加宫颈癌筛查者中选择加入与全面寄送HPV自取样方案的成本效果:Equalscreen随机对照试验
基于Equalscreen随机对照试验中6000名35-69岁、10年以上未筛查女性的数据,比较提醒信、选择加入(opt-in)和全面寄送(send-to-all)HPV自取样三种策略。结果显示全面寄送组参与率、CIN2+检出率和总筛查成本最高,选择加入组次之。从扩展医疗视角看,选择加入和全面寄送每增加1名筛查女性的ICER分别为135英镑和169英镑,每增加1例CIN2+检出的ICER分别为2864英镑和4165英镑;作者认为视支付意愿,二者可能被视为具有成本效果的选择。
要点
- 全面寄送HPV自取样组参与率、CIN2+检出率和总筛查成本均最高,选择加入组次之,提醒信组最低。
- 非组织学医师预约占提醒信组总成本的67%,占自取样组不超过31%。
- 选择加入和全面寄送每增加1名筛查女性的ICER分别为135英镑和169英镑。
核心结论
- 选择加入和全面寄送HPV自取样更有效,视支付意愿可能被视为改善挪威筛查参与率的具有成本效果的替代方案。
研究设计与样本
- 基于Equalscreen随机对照试验数据的二次分析,纳入6000名35-69岁、10年以上未筛查的女性,等比例随机分为提醒信组、选择加入自取样组和全面寄送自取样组。
- 成本效果以2020年英镑(GBP)估算,从扩展医疗和直接医疗视角计算每增加1名筛查女性和每增加1例CIN2+检出的增量成本效果比(ICER)。
主要发现
- 参与率、CIN2+检出率和总筛查成本均为全面寄送组最高,选择加入组次之,提醒信组最低。
- 非组织学医师预约占提醒信组总成本的67%,占自取样组不超过31%。
- 从扩展医疗视角看,选择加入组和全面寄送组每增加1名筛查女性的ICER分别为135英镑和169英镑。
- 从扩展医疗视角看,选择加入组和全面寄送组每增加1例CIN2+检出的ICER分别为2864英镑和4165英镑。
临床怎么用
- 作者认为,选择加入和全面寄送HPV自取样更有效,视支付意愿可能被视为改善挪威筛查参与率的具有成本效果的替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed the cost-effectiveness of mailing a human papillomavirus self-sampling (HPV-ss) kit, directly or via invitation to order, compared with mailing reminder letters among long-term non-attenders in Norway. METHODS: We conducted a secondary analysis using the Equalscreen study data with 6000 women aged 35-69 years who had not screened in 10+ years. Participants were equally randomized into three arms: reminder letter (control); invitation to order HPV-ss kit (opt-in); directly mailed HPV-ss kit (send-to-all). Cost-effectiveness (2020 Great British Pounds (GBP)) was estimated using incremental cost-effectiveness ratios (ICERs) per additional screened woman, and per additional cervical intraepithelial neoplasia grade 2 or worse (CIN2+) from extended and direct healthcare perspectives. RESULTS: Participation, CIN2+ detection, and total screening costs were highest in the send-to-all arm, followed by the opt-in and control arms. Non-histological physician appointments contributed to 67% of the total costs in the control arm and ≤ 31% in the self-sampling arms. From an expanded healthcare perspective, the ICERs were 135 GBP and 169 GBP per additional screened woman, and 2864 GBP and 4165 GBP per additional CIN2+ detected for the opt-in and send-to-all, respectively. CONCLUSIONS: Opt-in and send-to-all self-sampling were more effective and, depending on willingness-to-pay, may be considered cost-effective alternatives to improve screening attendance in Norway.
引用
- Knauss T, Hansen BT, Pedersen K, et al. The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: The Equalscreen randomized controlled trial. Gynecol Oncol. 2022. PMID: 36371904. doi:10.1016/j.ygyno.2022.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。